To check feasibility of resuming sanitiser export, Centre asks states about production capacity

Image
Press Trust of India New Delhi
Last Updated : May 14 2020 | 3:18 PM IST

To examine the feasibility of resuming export of alcohol-based hand sanitiser amid the COVID-19 pandemic, the central drugs controller has asked states and union territories to submit by Friday noon details of manufacturers, their production capacity and if they fulfil domestic demand.

The government had on May 6 banned exports of alcohol-based hand sanitiser to ensure its availability in the domestic market as the novel coronavirus cases soared in the country.

In a letter to the State and UT Drug Controllers on Wednesday, the Drugs Controller General of India (DCGI) has sought details of hand sanitiser manufacturers, including their names and addresses, average production capacity, and average actual monthly production in April 2020.

The DGCI has also sought to know whether the domestic supply request is being fulfilled by the firms and if the manufacturers have adequate supply and easy availability of raw materials such as ethanol and isopropyl alcohol.

"In view of the present situation due to outbreak of COVID-19 to assess the present situation of production, sufficiency of availability in domestic market and excess production (if any) of hand sanitiser in order to examine its feasibility for export purpose, it is requested to provide the following information of the manufacturing details of hand sanitiser...," the letter stated.

"Further based on your assessment it is also requested to inform that whether there is sufficient availability of hand sanitiser in your state/UTs. Whether hand sanitiser is being produced in excess quantity than demand (required for domestic market in India) by the firms so that the issue can be examined for its consideration of export feasibility," the letter read.

The state and Union territory drug controllers have been asked to submit the information through email by 12 noon of May 15.

The death toll due to COVID-19 rose to 2,549 and the number of cases climbed to 78,003 on Thursday, according to the Union Health Ministry.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 14 2020 | 3:18 PM IST

Next Story